As of Feb 17
| +0.04 / +0.79%|
The 1 analysts offering 12-month price forecasts for Cyclacel Pharmaceuticals Inc have a median target of 60.00, with a high estimate of 60.00 and a low estimate of 60.00. The median estimate represents a +1,078.78% increase from the last price of 5.09.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.